Earnings call: Axsome Therapeutics reports record quarterly revenue By...

Published on 12 Nov 2024 on Investing.com

The company's treatment for major depressive disorder, Auvelity, was a significant contributor with...

Read the rest of the article

Start tracking your investments with Statfolio

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this...

Insider Monkey · via Yahoo Finance 20 Feb 2025

Meanwhile, top-line data from the ENGAGE study and the SUSTAIN study, evaluating Sunosi for treat...

Zacks · via Yahoo Finance 19 Feb 2025

However, the growth potential is expected to have been partially offset by lower Kuvan sales. BMR...

Zacks · via Yahoo Finance 17 Feb 2025

Axsome therapeutics CFO sells $1.95 million in stock

Investing.com 15 Feb 2025

Axsome Therapeutics, Inc. (NASDAQ:AXSM) is possibly approaching a major achievement in its busine...

Simply Wall St. · via Yahoo Finance 6 Jan 2025

On Monday, Axsome Therapeutics, Inc. (NASDAQ:AXSM) released data from ACCORD-2, ADVANCE-2, and...

Benzinga · via Yahoo Finance 31 Dec 2024

Tesla, Avago among Monday’s market cap stock movers

Investing.com 30 Dec 2024

On Tuesday, Axsome Therapeutics Inc (NASDAQ:AXSM) said AXS-12 statistically significantly reduced...

Benzinga · via Yahoo Finance 27 Nov 2024

On Wednesday, RBC Capital Markets adjusted its outlook on shares of Axsome Therapeutics...

Investing.com 13 Nov 2024

The company's treatment for major depressive disorder, Auvelity, was a significant contributor wi...

Investing.com 12 Nov 2024